Tempest Therapeutics, Inc. — Director's Dealing 2013

Jun 11, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OvaScience, Inc. (OVAS)
CIK: 0001544227
Period of Report: 2013-06-07

Reporting Person: ALDRICH RICHARD (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-06-07	Stock Option (right to buy)	$14.00	A	4448	Acquired	2023-06-07	Common Stock (4448)	Direct

Footnotes

F1: The stock option will vest in twelve equal monthly installments at the end of each successive month following June 7, 2013.